Clinical Trial Update: Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of adding ramucirumab to nab-paclitaxel in previously treated advanced non-small cell lung cancer; trial comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ramucirumab + nab-paclitaxel

Snippet

Sponsor: Liza Villaruz, MD | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-19